# Data 

## Quality 

* Lorenzo Ruffino. [Perché i dati di “oggi” sull’epidemia non sono davvero... di oggi](https://www.pagellapolitica.it/blog/show/792/perché-i-dati-di-oggi-sullepidemia-non-sono-davvero-di-oggi). *Pagella Politica*

## Geospatial
* ISTAT, [Confini delle unità amministrative a fini statistici al 1° Gennaio 2020](https://www.istat.it/it/archivio/222527). (2020)
* OpenPolis. [Limits of Italian Provinces](https://github.com/openpolis/geojson-italy/blob/master/geojson/limits_IT_provinces.geojson). *GitHub* (2019)

## Population
* ISTAT, [Resident Population by Sex, Age and Marital Status](http://demo.istat.it/pop2020/index_e.html) (2020).
* ISTAT, [Population census data](http://dati.istat.it/Index.aspx?QueryId=18460) (2020).

## Contact
* Mossong J, Hens N, Jit M, Beutels P, Auranen K, Mikolajczyk R, et al. (2008) [Social Contacts and Mixing Patterns Relevant to the Spread of Infectious Diseases](https://doi.org/10.1371/journal.pmed.0050074). *PLoS Med* 5(3): e74. 
* Prem K, Cook AR, Jit M (2017). [Projecting social contact matrices in 152 countries using contact surveys and demographic data](https://doi.org/10.1371/journal.pcbi.1005697). *PLoS Comput Biol* 13(9).
* Kiesha Prem et al. (2020). [Projecting contact matrices in 177 geographical regions: an update and comparison with empirical data for the COVID-19 era](https://doi.org/10.1101/2020.07.22.20159772). *medRxiv pre-print*. 

## Mobility 
* Pepe, E., Bajardi, P., Gauvin, L. et al. [COVID-19 outbreak response, a dataset to assess mobility changes in Italy following national lockdown](https://doi.org/10.1038/s41597-020-00575-2). *Scientific Data* 7, 230 (2020).

## Diagnostic
* ECDC, [Strategies for the surveillance of COVID-19](https://www.ecdc.europa.eu/en/publications-data/strategies-surveillance-covid-19), 2020
* ECDC, [Diagnostic testing and screening for SARS-CoV-2](https://www.ecdc.europa.eu/en/covid-19/latest-evidence/diagnostic-testing), 2020
* ECDC, [Testing strategies](https://www.ecdc.europa.eu/en/covid-19/surveillance/testing-strategies), 2020
* European Commission (EC). [Current performance of COVID-19 test methods and devices and proposed performance criteria](https://ec.europa.eu/docsroom/documents/40805) (16 April 2020). Brussels: EC; [21 April, 2020]. 
* Jessica Watson et al. [Interpreting a covid-19 test result](https://doi.org/10.1136/bmj.m1808). *BMJ*, 2020.
* Edward C.Stites, Craig B.Wilen. [The Interpretation of SARS-CoV-2 Diagnostic Tests](https://doi.org/10.1016/j.medj.2020.08.001), *Med* (2020).
* Sethuraman N, Jeremiah SS, Ryo A. [Interpreting Diagnostic Tests for SARS-CoV-2](https://doi.org/10.1001/jama.2020.8259). *JAMA*. 2020;323(22):2249–2251.
* Diagnostics Committee of the Infectious Diseases Society of America (IDSA), [Molecular Testing for Acute Respiratory Tract Infections: Clinical and Diagnostic Recommendations From the IDSA’s Diagnostics Committee](https://doi.org/10.1093/cid/ciaa508), *Clinical Infectious Diseases*, , ciaa508
* [False Negative Tests for SARS-CoV-2 Infection — Challenges and Implications](https://doi.org/10.1056/NEJMp2015897) *N Engl J Med* 2020; 383:e38
* [Saliva or Nasopharyngeal Swab Specimens for Detection of SARS-CoV-2](https://doi.org/10.1056/NEJMc2016359) 
* Lisboa Bastos Mayara, Tavaziva Gamuchirai, Abidi Syed Kunal, Campbell Jonathon R, Haraoui Louis-Patrick, Johnston James C et al. [Diagnostic accuracy of serological tests for covid-19: systematic review and meta-analysis](https://doi.org/10.1136/bmj.m2516) *BMJ* 2020; 370 :m2516
* Kucirka, Lauren M., et al. [Variation in false-negative rate of reverse transcriptase polymerase chain reaction–based SARS-CoV-2 tests by time since exposure](https://doi.org/10.7326/M20-1495). *Annals of Internal Medicine* (2020).
* ISTAT, [First results of the SARS-CoV-2 seroprevalence study](https://www.istat.it/it/files//2020/08/ReportPrimiRisultatiIndagineSiero.pdf) (2020)
* Amy E Benefield et al. [SARS-CoV-2 viral load peaks prior to symptom onset: a systematic review and individual-pooled analysis of coronavirus viral load from 66 studies](https://doi.org/10.1101/2020.09.28.20202028). *medRxiv pre-print* (2020).
* Xinhua Chen et al. [Serological evidence of human infection with SARS-CoV-2: a systematic review and meta-analysis](https://doi.org/10.1101/2020.09.11.20192773). *medRxiv pre-print* (2020)
* Janko van Beek et al. [From more testing to smart testing: data-guided SARS-CoV-2 testing choices](https://doi.org/10.1101/2020.10.13.20211524). *medRxiv pre-print* (2020) 

## Epidemiological
* Our World in Data, [Data on COVID-19](https://github.com/owid/covid-19-data/tree/master/public/data).
* COVID-19 Routes, [Data Fetching for Italy](https://github.com/COVID-19-routes/data-model).
* PCM-DPC, [COVID-19 Data for Italy](https://github.com/pcm-dpc/COVID-19).
* ISS, [COVID-19 Integrated Surveillance](https://www.epicentro.iss.it/en/coronavirus/sars-cov-2-integrated-surveillance-data).
* ISTAT, [First results of the SARS-CoV-2 seroprevalence study](https://www.istat.it/it/files//2020/08/ReportPrimiRisultatiIndagineSiero.pdf) (2020)
* [Data and Information for COVID-19 Modeling](https://midasnetwork.us/covid-19/): Published estimates of epidemiological characteristics that have been peer-reviewed, encoded by community members and approved by authors.
### General 
* Khalili, M., Karamouzian, M., Nasiri, N., Javadi, S., Mirzazadeh, A., & Sharifi, H. (2020). [Epidemiological characteristics of COVID-19: A systematic review and meta-analysis](https://doi.org/10.1017/S0950268820001430). *Epidemiology and Infection*, 148, E130. 
* Oxford University Clinical Research Unit COVID-19 Research Group, [The Natural History and Transmission Potential of Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infection](https://doi.org/10.1093/cid/ciaa711), *Clinical Infectious Diseases*, ciaa711
### Transmission
*  Lu Qing-Bin et al. [Epidemiological parameters of COVID-19 and its implication for infectivity among patients in China, 1 January to 11 February 2020](https://doi.org/10.2807/1560-7917.ES.2020.25.40.2000250). *Euro Surveill.* 2020;25(40):pii=2000250. 
* Biggerstaff M, Cowling BJ, Cucunubá ZM, Dinh L, Ferguson NM, Gao H, et al., for the *WHO COVID-19 Modelling Parameters Group*. [Early insights from statistical and mathematical modeling of key epidemiologic parameters of COVID-19](https://doi.org/10.3201/eid2611.201074). *Emerg Infect Dis* (2020).
* Davies, N.G., Klepac, P., Liu, Y. et al. [Age-dependent effects in the transmission and control of COVID-19 epidemics](https://doi.org/10.1038/s41591-020-0962-9). *Nature Medicine* 26, 1205–1211 (2020). 
* Daniel P. Oran, Eric J. Topol. [Prevalence of Asymptomatic SARS-CoV-2 Infection: A Narrative Review](https://doi.org/10.7326/M20-3012) (2020).
* Ashcroft Petera et al. [COVID-19 infectivity profile correction](https://doi.org/10.4414/smw.2020.20336), *Swiss Med Wkly*. 2020;150:w20336
* Buitrago-Garcia D, Egli-Gany D, Counotte MJ, Hossmann S, Imeri H, Ipekci AM, et al. (2020) [Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: A living systematic review and meta-analysis](https://doi.org/10.1371/journal.pmed.1003346). PLoS Med 17(9): e1003346.
### Timing 
* Luca Ferretti et al. [The timing of COVID-19 transmission](https://doi.org/10.1101/2020.09.04.20188516). *medRxiv pre-print* (2020)
### R_t
* Flavia RIccardo et al. [Epidemiological characteristics of COVID-19 cases in Italy and estimates of the reproductive numbers one month into the epidemic](https://doi.org/10.1101/2020.04.08.20056861). *medRxiv pre-print* (2020)
* [National and Subnational estimates for Italy](https://epiforecasts.io/covid/posts/national/italy/): Identifying changes in the reproduction number, rate of spread, and doubling time during the course of the COVID-19 outbreak whilst accounting for potential biases due to delays in case reporting both nationally and subnationally in Italy. These results are impacted by changes in testing effort, increases and decreases in testing effort will increase and decrease reproduction number estimates respectively.
### Severity & Mortality 
* Robert Verity et al. [Estimates of the severity of coronavirus disease 2019: a model-based analysis](https://doi.org/10.1016/S1473-3099(20)30243-7). *The Lancet Infectious Disease* (2020)
* Poletti, Piero, et al. [Probability of symptoms and critical disease after SARS-CoV-2 infection](https://arxiv.org/abs/2006.08471). *arXiv pre-print* arXiv:2006.08471 (2020).
* Poletti Piero et al. [Age-specific SARS-CoV-2 infection fatality ratio and associated risk factors, Italy, February to April 2020](https://doi.org/10.2807/1560-7917.ES.2020.25.31.2001383). *Euro Surveill.* 2020;25(31):pii=2001383. 
* Andrew T. Levin et al. [Assessing the Age Specificity of Infection Fatality Rates for COVID-19: Systematic Review, Meta-Analysis, and Public Policy Implications](https://doi.org/10.1101/2020.07.23.20160895). *medRxiv pre-print* (2020)


## Policy 
* ECDC, [Guidelines for the implementation of non-pharmaceutical interventions against COVID-19](https://www.ecdc.europa.eu/en/publications-data/covid-19-guidelines-non-pharmaceutical-interventions), 2020.
* Desvars-Larrive, A., Dervic, E., Haug, N. et al. [A structured open dataset of government interventions in response to COVID-19](https://doi.org/10.1038/s41597-020-00609-9). *Scientific Data* 7, 285 (2020).
